J.D. Eneman

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer

Theresa Casey, Jeffrey P. Bond, Scott Tighe et al. · Breast Cancer Research and Treatment · 2008 · 220 citations

Medicine, Cell Biology, Molecular Biology +17

Characterization of cadmium-induced apoptosis in rat lung epithelial cells: evidence for the participation of oxidant stress

Beth A. Hart, C.H. Lee, G. S. Shukla et al. · Toxicology · 1999 · 198 citations

Veterinary Medicine, Cell Biology, Toxicology +14

Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor‐bearing microparticles: a randomized‐controlled phase II trial (the Microtec study)

Jeffrey I. Zwicker, Howard A. Liebman, Kenneth A. Bauer et al. · British Journal of Haematology · 2012 · 138 citations · Full text

Medicine, Oncology, Pharmacology +17

Cancer associated fibroblasts stimulated by transforming growth factor beta1 (TGF-β1) increase invasion rate of tumor cells: a population study

Theresa Casey, J.D. Eneman, Abigail Crocker et al. · Breast Cancer Research and Treatment · 2007 · 125 citations

Medicine, Cell Biology, Oncology +14